96 related articles for article (PubMed ID: 21680603)
1. Association of human cytomegalovirus viremia with human leukocyte antigens in liver transplantation recipients.
Hu J; Meng X; Zhao H; Zhang X; Gao H; Yang M; Ma Y; Li M; Ma W; Fan J
Acta Biochim Biophys Sin (Shanghai); 2011 Jul; 43(7):576-81. PubMed ID: 21680603
[TBL] [Abstract][Full Text] [Related]
2. The effect of HLA class I (A and B) and class II (DR) compatibility on liver transplantation outcomes: an analysis of the OPTN database.
Navarro V; Herrine S; Katopes C; Colombe B; Spain CV
Liver Transpl; 2006 Apr; 12(4):652-8. PubMed ID: 16555339
[TBL] [Abstract][Full Text] [Related]
3. Association of cytomegalovirus infection with human leukocyte antigen genotypes in recipients after allogeneic liver transplantation.
Fan J; Meng XQ; Yang MF; Zhou L; Chen XM; Hu MJ; Fan WW; Ma WH; Li LJ
Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):34-8. PubMed ID: 16481279
[TBL] [Abstract][Full Text] [Related]
4. [The study on high-resolution HLA and human cytomegalovirus (HCMV) viremia in bone marrow transplantation recipients].
Ma YD; Li MH; Meng XQ; Huang YP; Hu JH; Chin XM; Fan J; Ma WH
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Dec; 25(6):427-30. PubMed ID: 22734226
[TBL] [Abstract][Full Text] [Related]
5. Influence of human leukocyte antigen mismatching on rejection development and allograft survival in liver transplantation: is the relevance of HLA-A locus matching being underestimated?
Muro M; López-Álvarez MR; Campillo JA; Marin L; Moya-Quiles MR; Bolarín JM; Botella C; Salgado G; Martínez P; Sánchez-Bueno F; López-Hernández R; Boix F; Bosch A; Martínez H; de la Peña-Moral JM; Pérez N; Robles R; García-Alonso AM; Minguela A; Miras M; Alvarez-López MR
Transpl Immunol; 2012 Mar; 26(2-3):88-93. PubMed ID: 22129495
[TBL] [Abstract][Full Text] [Related]
6. Impact of human leukocyte antigen matching on hepatitis B virus recurrence after liver transplantation.
Zhao H; Hu JH; Zhou L; Xu X; Wu J; Meng XQ; Fan J; Ma WH
Hepatobiliary Pancreat Dis Int; 2010 Apr; 9(2):139-43. PubMed ID: 20382583
[TBL] [Abstract][Full Text] [Related]
7. Influence of human leukocyte antigen matching on liver allograft survival and rejection: "the dualistic effect".
Donaldson P; Underhill J; Doherty D; Hayllar K; Calne R; Tan KC; O'Grady J; Wight D; Portmann B; Williams R
Hepatology; 1993 Jun; 17(6):1008-15. PubMed ID: 8514248
[TBL] [Abstract][Full Text] [Related]
8. Detection of human leukocyte antigen compatibility and antibodies in liver transplantation in China.
Meng XQ; Zhang X; Fan J; Zhou L; Hao B; Chen XM; Ma WH; Zheng SS
Hepatobiliary Pancreat Dis Int; 2009 Apr; 8(2):141-5. PubMed ID: 19357026
[TBL] [Abstract][Full Text] [Related]
9. Cytomegalovirus infection in renal transplant recipients: one center's experience.
Bal Z; Uyar ME; Tutal E; Erdogan E; Colak T; Sezer S; Haberal M
Transplant Proc; 2013; 45(10):3520-3. PubMed ID: 24314948
[TBL] [Abstract][Full Text] [Related]
10. Human leukocyte antigen and adult living-donor liver transplantation outcomes: an analysis of the organ procurement and transplantation network database.
Jakab SS; Navarro VJ; Colombe BW; Daskalakis C; Herrine SK; Rossi S
Liver Transpl; 2007 Oct; 13(10):1405-13. PubMed ID: 17902126
[TBL] [Abstract][Full Text] [Related]
11. Preformed antibodies detected by cytotoxic assay or multibead array decrease liver allograft survival: role of human leukocyte antigen compatibility.
Castillo-Rama M; Castro MJ; Bernardo I; Meneu-Diaz JC; Elola-Olaso AM; Calleja-Antolin SM; Romo E; Morales P; Moreno E; Paz-Artal E
Liver Transpl; 2008 Apr; 14(4):554-62. PubMed ID: 18383092
[TBL] [Abstract][Full Text] [Related]
12. Monitoring of human Cytomegalovirus infection by antigenemia and viremia in the first 100 days following renal transplantation and relation to antiviral strategies.
Terlizzi ME; Costa C; Astegiano S; Sidoti F; Vendrame R; Segoloni GP; Bergallo M; Cavallo R
Minerva Med; 2008 Jun; 99(3):231-9. PubMed ID: 18497721
[TBL] [Abstract][Full Text] [Related]
13. The effect of HLA mismatches, shared cross-reactive antigen groups, and shared HLA-DR antigens on the outcome after pediatric liver transplantation.
Sieders E; Hepkema BG; Peeters PM; TenVergert EM; de Jong KP; Porte RJ; Bijleveld CM; van den Berg AP; Lems SP; Gouw AS; Slooff MJ
Liver Transpl; 2005 Dec; 11(12):1541-9. PubMed ID: 16315307
[TBL] [Abstract][Full Text] [Related]
14. Combined HLA-DR and -DQ disparity is associated with a stable course of ulcerative colitis after liver transplantation for primary sclerosing cholangitis.
Cholongitas E; Papatheodoridis GV; Zappoli P; Giannakopoulos A; Patch D; Marelli L; Shusang V; Kalambokis G; Shirling G; Rolando N; Burroughs AK
Liver Transpl; 2007 Apr; 13(4):552-7. PubMed ID: 17394153
[TBL] [Abstract][Full Text] [Related]
15. Effect of partial HLA class I match on acute rejection in viral pre-infected human liver allograft recipients.
Ontañón J; Muro M; García-Alonso AM; Minguela A; Torío A; Bermejo J; Pons JA; Campos M; Alvarez-López MR
Transplantation; 1998 Apr; 65(8):1047-53. PubMed ID: 9583864
[TBL] [Abstract][Full Text] [Related]
16. HLA compatibility and liver transplant outcome. Improved patient survival by HLA and cross-matching.
Nikaein A; Backman L; Jennings L; Levy MF; Goldstein R; Gonwa T; Stone MJ; Klintmalm G
Transplantation; 1994 Oct; 58(7):786-92. PubMed ID: 7940711
[TBL] [Abstract][Full Text] [Related]
17. Role of Human Leukocyte Antigen Compatibility in Graft Outcomes After Living Donor Liver Transplantation.
Shin M; Kim JM; Kwon CH; Kim SJ; Joh JW
Transplant Proc; 2016 May; 48(4):1123-9. PubMed ID: 27320571
[TBL] [Abstract][Full Text] [Related]
18. Influence of HLA matching on survival in heart transplantation.
Almenar L; Maeso ML; Martínez-Dolz L; Rueda J; Palomar CG; Sáez AO; Vives MA; Tort MD; Pérez MP
Transplant Proc; 2005 Nov; 37(9):4001-5. PubMed ID: 16386610
[TBL] [Abstract][Full Text] [Related]
19. Influence of donor/recipient HLA-matching on outcome and recurrence of hepatitis C after liver transplantation.
Langrehr JM; Puhl G; Bahra M; Schmeding M; Spinelli A; Berg T; Schönemann C; Krenn V; Neuhaus P; Neumann UP
Liver Transpl; 2006 Apr; 12(4):644-51. PubMed ID: 16555324
[TBL] [Abstract][Full Text] [Related]
20. Monitoring HCMV infection with quantitative real-time PCR in HCMV-positive orthotopic liver transplant recipients, and predictive factors for treatment of the first episode of HCMV viremia.
Pillet A; Mengelle C; Basse G; Ribes D; Kamar N; Muscari F; Lavayssière L; Suc B; Esposito L; Peron JM; Rostaing L
Transplant Proc; 2006 Sep; 38(7):2335-8. PubMed ID: 16980083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
